Literature DB >> 21809318

Animal models of mycobacteria infection.

Diane J Ordway1, Ian M Orme.   

Abstract

This unit describes the infection of mice and guinea pigs with mycobacteria via various routes, as well as necropsy methods for the determination of mycobacterial loads within target organs. Additionally, methods for cultivating mycobacteria and preparing stocks are described. The protocols outlined are primarily used for M. tuberculosis, but can also be used for the study of other non-tuberculosis mycobacterial species.
© 2011 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21809318     DOI: 10.1002/0471142735.im1905s94

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  14 in total

1.  Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372.

Authors:  Mohamed Aiyaz; Chand Bipin; Vinay Pantulwar; Raja Mugasimangalam; Crystal A Shanley; Diane J Ordway; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2014-12       Impact factor: 3.131

2.  IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosis.

Authors:  Aurelie A Ray; Jeffrey J Fountain; Halli E Miller; Andrea M Cooper; Richard T Robinson
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

Review 3.  Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.

Authors:  Kevin B Urdahl
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

Review 4.  Vaccine development for tuberculosis: current progress.

Authors:  Ian M Orme
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

5.  Early control of Mycobacterium tuberculosis infection requires il12rb1 expression by rag1-dependent lineages.

Authors:  Halli E Miller; Richard T Robinson
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

6.  MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages.

Authors:  Devram Sampat Ghorpade; Rebecca Leyland; Mariola Kurowska-Stolarska; Shripad A Patil; Kithiganahalli Narayanaswamy Balaji
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

Review 7.  Current and novel approaches to vaccine development against tuberculosis.

Authors:  Mark J Cayabyab; Lilia Macovei; Antonio Campos-Neto
Journal:  Front Cell Infect Microbiol       Date:  2012-12-06       Impact factor: 5.293

8.  Flow Cytometry Analysis and Fluorescence-activated Cell Sorting of Myeloid Cells from Lung and Bronchoalveolar Lavage Samples from Mycobacterium tuberculosis-infected Mice.

Authors:  Alissa C Rothchild; Dat Mai; Alan Aderem; Alan H Diercks
Journal:  Bio Protoc       Date:  2020-05-20

9.  Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis.

Authors:  Lluís Ballell; Robert H Bates; Rob J Young; Daniel Alvarez-Gomez; Emilio Alvarez-Ruiz; Vanessa Barroso; Delia Blanco; Benigno Crespo; Jaime Escribano; Rubén González; Sonia Lozano; Sophie Huss; Angel Santos-Villarejo; José Julio Martín-Plaza; Alfonso Mendoza; María José Rebollo-Lopez; Modesto Remuiñan-Blanco; José Luis Lavandera; Esther Pérez-Herran; Francisco Javier Gamo-Benito; José Francisco García-Bustos; David Barros; Julia P Castro; Nicholas Cammack
Journal:  ChemMedChem       Date:  2013-01-10       Impact factor: 3.466

10.  Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis.

Authors:  Eduardo P Amaral; Simone C M Ribeiro; Verônica R Lanes; Fabrício M Almeida; Marcelle R M de Andrade; Caio Cesar Barbosa Bomfim; Erika M Salles; Karina R Bortoluci; Robson Coutinho-Silva; Mario H Hirata; José M Alvarez; Elena B Lasunskaia; Maria Regina D'Império-Lima
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.